Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | TP53 | P04637 | 2/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL252166 | 0.88 | — | — | |
| SCHEMBL252167 | 0.88 | — | — | |
| SCHEMBL27557763 | 0.77 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL211113 | 0.76 | CYP3A4 (0.39) | TSHRALDH1A1CYP3A4HSD17B10 | |
| SCHEMBL244291 | 0.72 | TSHR (0.35) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL11102191 | 0.71 | — | — | |
| SCHEMBL462908 | 0.71 | TSHR (0.34) | TSHRALDH1A1HSD17B10 | |
| SCHEMBL462909 | 0.71 | TSHR (0.34) | TSHRALDH1A1HSD17B10 | |
| SCHEMBL6125522 | 0.70 | — | — | |
| SCHEMBL49388 | 0.70 | ALDH1A1 (0.32) | TSHRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2012500273-A | — | — | 2012-01-05 | — | — | JP | claimed |
| EP-2334635-A2 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | Nalco Company (US) | 2011-06-22 | — | — | EP | claimed |
| US-20100048951-A1 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | ECOLAB USA INC. | 2010-02-25 | — | — | US | claimed |
| WO-2010021956-A2 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | NALCO COMPANY (US) | 2010-02-25 | — | — | WO | claimed |
| US-8445723-B2 | Processes for producing N-alkyl (alkyl)acrylamides | NALCO COMPANY (US) | 2013-05-21 | — | — | US | disclosed |
| EP-2334635-A2 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | Nalco Company (US) | 2011-06-22 | — | — | EP | disclosed |
| US-20100048951-A1 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | ECOLAB USA INC. | 2010-02-25 | — | — | US | disclosed |
| WO-2010021956-A2 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | NALCO COMPANY (US) | 2010-02-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100048951-A1 | PROCESSES FOR PRODUCING N-ALKYL (ALKYL)ACRYLAMIDES | ACR, NAAA, INA | TSHR 4245/4885ALDH1A1 396/4885TP53 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.